Legal Opinion
Navidea Biopharmaceuticals, Inc. and MacRophage Therapeutics, Inc. v. Capital Royalty Partners II, L.P., Capital Royalty Partners II - Parallel Fund "A", L.P., Capital Royalty Partners II (Cayman) L.P., and Capital Royalty Partners II - Parallel Fund "B" (Cayman) L.P.
Texas Court of Appeals, 14th District (Houston)
Decided July 16, 2019No. 14-18-00225-CVPublished
1Opinion of the Court
Dismissed and Memorandum Opinion filed July 16, 2019. In The Fourteenth Court of Appeals NO. 14-18-00225-CV NAVIDEA BIOPHARMACEUTICALS, INC. AND MACROPHAGE THERAPEUTICS, INC., Appellants V. CAPITAL ROYALTY PARTNERS II, L.P., CAPITAL ROYALTY PARTNERS II - PARALLEL FUND “A”, L.P., CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P., AND CAPITAL ROYALTY PARTNERS II - PARALLEL FUND “B” (CAYMAN) L.P., Appellees On Appeal from the 151st District Court Harris County, Texas Trial Court Cause No. 2016-22242 MEMORANDUM OPINION This case involves a commercial loan dispute resolved by a high-low settlement…
2Cases cited11 opinions
- Hallock v. StateNew York Court of Appeals · 1984
- McCoy v. FeinmanNew York Court of Appeals · 2002
- Barsness v. Scott, Texas Court of Appeals, 4th District (San Antonio)2003
- Cunha v. ShapiroAppellate Division of the Supreme Court of the State of New York · 2007
- Brown v. EubankCourt of Appeals of Texas · 1969
6 more not listed; retrieve them via the Exa API.